News

Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / June 17, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and ...
Tharimmune Inc.: Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / June 17, 2025 / Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and ...